370 related articles for article (PubMed ID: 21393972)
1. Retrospective analysis of basal cell carcinoma.
Hakverdi S; Balci DD; Dogramaci CA; Toprak S; Yaldiz M
Indian J Dermatol Venereol Leprol; 2011; 77(2):251. PubMed ID: 21393972
[TBL] [Abstract][Full Text] [Related]
2. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study of 694 Basal Cell Carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin.
Kiely JR; Patel AJK
J Plast Reconstr Aesthet Surg; 2019 Nov; 72(11):1805-1812. PubMed ID: 31331722
[TBL] [Abstract][Full Text] [Related]
4. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
5. Basosquamous cell carcinoma: a survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomas.
Betti R; Crosti C; Ghiozzi S; Cerri A; Moneghini L; Menni S
Eur J Dermatol; 2013; 23(1):83-6. PubMed ID: 23238332
[TBL] [Abstract][Full Text] [Related]
6. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases.
Farhi D; Dupin N; Palangié A; Carlotti A; Avril MF
Dermatol Surg; 2007 Oct; 33(10):1207-14. PubMed ID: 17903153
[TBL] [Abstract][Full Text] [Related]
7. Basal cell carcinoma: histological classification and body-site distribution.
Raasch BA; Buettner PG; Garbe C
Br J Dermatol; 2006 Aug; 155(2):401-7. PubMed ID: 16882181
[TBL] [Abstract][Full Text] [Related]
8. Clinical and histopathological characteristics of basal cell carcinoma in Chinese patients.
Chang JM; Gao XM
Chin Med J (Engl); 2013 Jan; 126(2):211-4. PubMed ID: 23324265
[TBL] [Abstract][Full Text] [Related]
9. Follow-up of basal cell carcinomas: an audit of current practice.
Mc Loone NM; Tolland J; Walsh M; Dolan OM
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):698-701. PubMed ID: 16836498
[TBL] [Abstract][Full Text] [Related]
10. Margin involvement and clinical pattern of basal cell carcinoma with mixed histology.
Betti R; Radaelli G; Crosti C; Ghiozzi S; Moneghini L; Menni S
J Eur Acad Dermatol Venereol; 2012 Apr; 26(4):483-7. PubMed ID: 21545546
[TBL] [Abstract][Full Text] [Related]
11. Recurrent morphean basal cell carcinoma of the skin. A clinico-histopathological study of 97 cases.
Anthouli-Anagnostopoulou F; Hatziolou E
Adv Clin Path; 2002 Jan; 6(1):17-24. PubMed ID: 17582944
[TBL] [Abstract][Full Text] [Related]
12. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
13. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
14. Factors contributing to incomplete excision of nonmelanoma skin cancer by Australian general practitioners.
Hansen C; Wilkinson D; Hansen M; Soyer HP
Arch Dermatol; 2009 Nov; 145(11):1253-60. PubMed ID: 19917954
[TBL] [Abstract][Full Text] [Related]
15. Basal cell carcinoma characteristics as predictors of depth of invasion.
Welsch MJ; Troiani BM; Hale L; DelTondo J; Helm KF; Clarke LE
J Am Acad Dermatol; 2012 Jul; 67(1):47-53. PubMed ID: 22507669
[TBL] [Abstract][Full Text] [Related]
16. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes.
McCormack CJ; Kelly JW; Dorevitch AP
Arch Dermatol; 1997 May; 133(5):593-6. PubMed ID: 9158412
[TBL] [Abstract][Full Text] [Related]
17. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
18. Eyelid basal cell carcinoma: non-Mohs excision, repair, and outcome.
Hamada S; Kersey T; Thaller VT
Br J Ophthalmol; 2005 Aug; 89(8):992-4. PubMed ID: 16024851
[TBL] [Abstract][Full Text] [Related]
19. Incomplete primary excision of cutaneous basal and squamous cell carcinomas in the Bay of Plenty.
Talbot S; Hitchcock B
N Z Med J; 2004 Apr; 117(1192):U848. PubMed ID: 15107870
[TBL] [Abstract][Full Text] [Related]
20. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]